Amygdala volume in schizophrenia: post-mortem study and review of magnetic resonance imaging findings

Steven A Chance1, Margaret M Esiri, Timothy J Crow

  • 1University of Oxford, UK. steven.chance@clneuro.ox.ac.uk

Abstract

Insights

Post-mortem studies found no significant amygdala volume reduction in schizophrenia patients. This suggests that reduced amygdala volume is not a consistent feature of schizophrenia, challenging previous magnetic resonance imaging findings.

Area of Science:

  • Neuroscience
  • Psychiatry

Background:

  • Schizophrenia is increasingly linked to the limbic system, supported by magnetic resonance imaging (MRI) studies indicating reduced hippocampus and amygdala volumes.
  • However, some post-mortem studies have not corroborated these volumetric abnormalities.

Purpose of the Study:

  • To investigate amygdala volume in post-mortem brains of individuals with schizophrenia.
  • To address discrepancies between MRI and post-mortem findings regarding amygdala size in schizophrenia.

Main Methods:

  • Amygdala volume was quantified using point-counting techniques on both hemispheres.
  • The study included post-mortem brains from 10 male and 8 female patients diagnosed with schizophrenia.
  • A comparison group comprised 9 males and 9 females without schizophrenia.

Main Results:

  • No statistically significant reduction in amygdala volume was observed in patients with schizophrenia compared to the control group.
  • These findings indicate that amygdala volume reduction is not a universal characteristic of schizophrenia.

Conclusions:

  • The study concludes that significant amygdala volume reduction is not a consistent neuropathological finding in schizophrenia.
  • Discrepancies with prior MRI meta-analyses may stem from methodological biases in early imaging studies, such as coarse delineation methods.